Researcher Profiles

Return to member profile

Sharathkumar M. Bhagavathi, MD

Publications since 2011

Johnson-Farley, N. Veliz, J. Bhagavathi, S. Bertino, J. R. ABT-199, a BH3 Mimetic That Specifically Targets Bcl-2, Enhances the Antitumor Activity of Chemotherapy, Bortezomib, and JQ1 in "Double Hit " Lymphoma cells. Leuk Lymphoma, In process, . (PMID: 25373508)

Li, S. Seegmiller, A. C. Lin, P. Wang, X. J. Miranda, R. N. Bhagavathi, S. Medeiros, L. J. B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas. Mod Pathol, In process, . (PMID: 25103070)

Bhagavathi, S. Fu, K. Primary lymphoma of bone: A review. Semin Diagn Pathol, 31:48-52, . (PMID: 24680182)

Bertino, J. R. Lubin, M. Johnson-Farley, N. Chan, W. C. Goodell, L. Bhagavathi, S. Lack of Expression of MTAP in Uncommon T-Cell Lymphomas. Clin Lymphoma Myeloma Leuk, 12:306-309, . (PMID: 23040436)